Saturday, October 16, 2021
Advertisement

Waypoint planning to deploy more capital in healthcare real estate

Real estate asset manager and advisor Waypoint Asset Management has said it is looking to deploy more capital in healthcare property over the next...
Fertility experts urge IVF clinics to share success rates

Warrington-based fertility specialist agrees merger with IVF Life Group

Warrington-based IVF clinic Reproductive Health Group (RHG) has agreed a merger with Spanish fertility group IVF Life Group. Financial details of the transaction have not...

Elysium Healthcare investors hire JP Morgan to handle sale

Private equity firm BC Partners, owners of Elysium Healthcare, has appointed investment bank JP Morgan to run the sale of the mental health services...

Addiction rehab provider extends portfolio with acquisition

The UK Addiction Treatment Group (UKAT) has completed a deal to buy Linwood House Treatment Centre from the Care Plus Group in Barnsley, South...

Assura in strong position to partner NHS during challenging period

The CEO of specialist healthcare REIT Assura said today that the company remains in a strong position to partner with the NHS as it...

Acquisitions drive growth at Portman Healthcare

UK dental group Portman Healthcare has reported a 40% jump in turnover as acquisitions and the launch of its dedicated orthodontic business boosted 2019...

IDH appoints advisors to explore potential sale

Carlisle and Palamon-backed dental group Integrated Dental Holdings (IDH) has appointed advisors to explore a potential sale process. The Group, which operates high street dental...

Pharma deals boost revenue at London-listed Sensyne

Deals with major pharmaceutical companies have boosted revenue at clinical AI company Sensyne Health. The London-listed company reported revenue of £2.1m for the year ended 30...

Advanced Oncotherapy on track with LIGHT system

Advanced Oncotherapy (AVO) has reported continued progress in the development of its next-generation proton beam therapy system, LIGHT, despite the challenges of the Covid-19...
Sensyne Health CEO Paul Drayson

US investor takes stake in Sensyne Health

Nasdaq-listed technology investor Acacia Research Corporation has acquired an 11.8% stake in UK-based clinical AI company Sensyne Health. Precise terms of the deal have not...